Vir Biotechnology

VIR

8.9053.07% ( +0.265 )

Trading: Jul 30, 15:06:42 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Vir Biotechnology(VIR) predict that the Revenue is -29 K (-101%), Miss estimate;the EBIT is -132.29 M (+5.2%), Miss estimate;the EPS is -0.85 (+3.41%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

-0.00B100.96%

0.11B3504.39%

-0.11B3,605.35%

EBITMiss expectations

-0.13B5.20%

-0.00B98.26%

-0.13B93.06%

EPSMiss expectations

-0.853.41%

0.08109.09%

-0.9300105.68%

Upcoming earnings report - FY2026 Q2 Earning Release

Available dateAug 5, 2026

Estimate Revenue222.57 M

Estimate EBIT76.08 M

Estimate EPS0.6575

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD